Equities Analysts Set Expectations for TSE:MSL Q2 Earnings

Merus Labs International Inc. (TSE:MSLFree Report) (NASDAQ:MSLI) – Investment analysts at HC Wainwright lifted their Q2 2026 earnings per share estimates for Merus Labs International in a research note issued to investors on Monday, May 18th. HC Wainwright analyst A. He now anticipates that the specialty pharmaceutical company will earn ($0.49) per share for the quarter, up from their previous forecast of ($0.50). HC Wainwright also issued estimates for Merus Labs International’s Q3 2026 earnings at ($0.49) EPS, Q4 2026 earnings at ($0.49) EPS, FY2026 earnings at ($2.20) EPS, Q1 2027 earnings at ($0.54) EPS, Q2 2027 earnings at ($0.58) EPS, Q3 2027 earnings at ($0.63) EPS, Q4 2027 earnings at ($0.67) EPS, FY2027 earnings at ($2.42) EPS, FY2028 earnings at ($2.57) EPS and FY2029 earnings at ($1.59) EPS.

Other analysts have also issued research reports about the company. Guggenheim raised Merus Labs International to a “strong-buy” rating in a research note on Tuesday, April 28th. Leerink Partners upgraded Merus Labs International to a “strong-buy” rating in a research report on Monday, April 6th. Finally, Cantor Fitzgerald upgraded Merus Labs International to a “strong-buy” rating in a research report on Wednesday, March 11th. Three research analysts have rated the stock with a Strong Buy rating, According to MarketBeat, the stock currently has an average rating of “Strong Buy”.

Read Our Latest Research Report on Merus Labs International

Merus Labs International Price Performance

Merus Labs International has a 52 week low of C$0.95 and a 52 week high of C$1.76.

About Merus Labs International

(Get Free Report)

Merus Labs International Inc is a specialty pharmaceutical company. The Company is engaged in the acquisition and licensing of branded prescription pharmaceutical products. The Company’s products include Elantan, Isoket, Deponit, Sintrom, Emselex/Enablex, Surgestone, Provames, Speciafoldine, Tredemine, Salagen, Estraderm MX and Vancocin. Elantan are tablets or capsules that belong to a group of medicines called organic nitrates. Isoket belongs to a group of medicines called organic nitrates. Deponit belongs to a group of medicines called nitrates.

Featured Stories

Earnings History and Estimates for Merus Labs International (TSE:MSL)

Receive News & Ratings for Merus Labs International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merus Labs International and related companies with MarketBeat.com's FREE daily email newsletter.